Tumor-initiating cells (TICs) are a sub-population of cells that exhibit a robust ability to self-renew and contribute to the formation of primary tumors, the relapse of previously treated tumors and the development of metastases. TICs have been identified in various tumors including those of the breast, and are particularly enriched in the basal-like and claudin-low subtypes of breast cancer. The signaling pathways that contribute to the function and maintenance of TICs are under intense study. We explored the potential involvement of the nuclear factor-kB (NF-kB) family of transcription factors in TICs in cell lines that are representative of basal-like and claudin-low breast cancer. NF-kB was found to be activated in breast cancer cells that form tumorspheres efficiently. Moreover, both canonical and non-canonical NF-kB signaling is required for these cells to self-renew in vitro and to form xenograft tumors efficiently in vivo using limiting dilutions of cells. Consistent with this fact, canonical and non-canonical NF-kB signaling is activated in TICs isolated from breast cancer cell lines. Experimental results indicate that NF-kB promotes the function of TICs by stimulating epithelial-to-mesenchymal transition and by upregulating the expression of the inflammatory cytokines interleukin-1b and interleukin-6. The results suggest the use of NF-kB inhibitors for clinical therapy of certain breast cancers.
INTRODUCTION
Tumors are comprised of a heterogeneous population of cells including bulk epithelial tumor cells, inflammatory cells and subpopulation of cells termed cancer stem cells or tumor-initiating cells (TICs). 1 The primary characteristic of TICs is their ability to selfrenew, which is measured in vitro by the formation of spheroid cellular structures termed tumorspheres. 2, 3 In addition, TICs exhibit elevated motility and invasiveness in vitro that correlates with high metastatic potential in vivo, [4] [5] [6] and are frequently radio- 7, 8 and chemo-resistant. 9, 10 Importantly, TICs are thought to drive the progression of primary tumors, promote tumor recurrence and stimulate the development of metastases at distant sites. 4, 5 The importance of TICs in the clinical outcome of breast cancer is evidenced by the observation that an increase in their abundance following initial systemic treatment correlates with worse prognosis. 11 TICs have been observed in multiple subtypes of human breast cancer 12 and are particularly enriched in the basal-like and claudin-low subtypes. [12] [13] [14] The nuclear factor-kB (NF-kB) family of transcription factors contains five members, p65 (RelA), RelB, c-Rel, p105/p50 and p100/p52. 15, 16 In most cells, NF-kB proteins exist as hetero-and homodimers in the cytoplasm bound to a class of inhibitory proteins called IkBs (inhibitor of kB). In response to a wide variety of cellular stimuli, NF-kB becomes active through one of two pathways. In the canonical pathway, NF-kB activation depends on the IkB kinase complex (IKK), which contains two catalytic subunits, IKKa and IKKb, and a regulatory subunit, IKKg or NEMO. Upon stimulation, IkBa is phosphorylated at Ser32/36 by IKK in a manner that requires IKKb, which results in the degradation of IkBa and the release of the p65-p50 dimer to accumulate in the nucleus. 15 Phosphorylation of p65 at Ser536 by IKK is also important for its activity. 17 Separately, the noncanonical NF-kB pathway is regulated by an IKKa homodimer. In this cascade, RelB-p100 heterodimers are processed to RelB-p52 heterodimers in a manner that depends on IKKa. In the nucleus, NF-kB dimers activate genes including those involved in cell cycle regulation (for example, cyclin D1), suppression of apoptosis (for example, Bcl-2 and Bcl-xL) and inflammation (for example, cytokines such as interleukin (IL)-6 and IL-8). 15 Activation of NF-kB is strongly associated with oncogenesis, as it is known to promote the oncogenic phenotype through processes including cell proliferation, inflammation, cell invasion and suppression of apoptosis. 18, 19 Consistent with this fact, both canonical and non-canonical NF-kB signaling is activated in human breast cancer cell lines and primary breast tumors. [20] [21] [22] [23] [24] Recently, IKK/NF-kB was shown to be important in TICs isolated from HER2 þ breast cancer. 25, 26 Others have observed that NF-kB functions to promote proliferation in basal-like breast cancer cells. 27 Here, we have explored a potential role for NF-kB in TIC function in cells derived from basal-like and claudin-low breast cancer cells. Specifically, we show that NF-kB signaling is more highly activated in breast cancer cell lines that undergo efficient self-renewal. Moreover, inhibition of either canonical or noncanonical NF-kB signaling blunts the self-renewal of human breast cancer cells in vitro. Inhibition of NF-kB also reduces the formation of xenograft tumors in the mammary fat pads of nude mice in vivo. Mechanistically, we provide evidence that NF-kB promotes the function of TICs through stimulation of epithelial-to-mesenchymal transition (EMT) and the production of inflammatory cytokines that are encoded by NF-kB target genes. Collectively, these data demonstrate that canonical and non-canonical NF-kB signaling have critical roles in the function of TICs derived from basal-like and claudin-low subtypes of breast cancer cells.
RESULTS
NF-kB signaling is preferentially activated in tumorsphere-forming breast cancer cells Cell lines representing the basal-like subtype (SUM149) and claudin-low subtype (MDA-MB231) of breast cancer were utilized to investigate the role of NF-kB in the function of TICs. A hallmark of breast cancer TICs is the ability to drive the formation of spheroid structures termed tumorspheres (or mammospheres) in serum-free culture, which reflects the ability of these cells to self-renew in vitro (reviewed in Charafee-Jauffret et al. 2 and Pastrana et al. 28 ). It was observed that both SUM149 and MDA-MB231 cells efficiently form tumorspheres over at least three cycles of culture ( Figure 1a ). It was then determined whether the ability of basal-like and claudin-low cancer cells to form tumorspheres correlates with the level of basal NF-kB activation in the bulk population. Importantly, both p65 and IkBa are preferentially phosphorylated in SUM149 and MDA-MB231 cells that form tumorspheres efficiently compared with MCF10A cells that form tumorspheres less efficiently (Figures 1a and b ). 29 Canonical NF-kB signaling is required for basal-like breast cancer cells to efficiently self-renew in vitro To inhibit NF-kB, SUM149 cells were stably infected with a retrovirus expressing either an empty vector or IkBa-SR (a modified form of IkBa that cannot be phosphorylated) and selected with puromycin ( Figure 2a ). To assay for self-renewal, 100 SUM149 cells expressing empty vector or IkBa-SR were plated in serum-free media on low-adhesion plates and the number of tumorspheres were determined 5 days later. Importantly, cells in which NF-kB was inhibited by expression of IkBa-SR formed threefold fewer tumorspheres than control cells, expressing an empty vector ( Figure 2b ). To confirm these results, an RNA interference knockdown approach was utilized. SUM149 cells were stably infected with an empty lentiviral vector, a lentivirus encoding a scrambled short hairpin RNA (shRNA) or a lentivirus encoding a shRNA construct targeting p65 or IKKb ( Figure 2c ). Subsequently, self-renewal of these cells was assayed through tumorsphere formation as described above. Importantly, knockdown of either p65 or IKKb resulted in a statistically significant, approximately fivefold reduction in the ability of SUM149 cells to form tumorspheres ( Figure 2d ). Notably, expression of IkBa-SR, or knockdown of IKKb or p65 does not alter the growth of SUM149 cells as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay ( Supplementary Figures 1a and b ). In addition, further analysis demonstrated that tumorspheres were arising from single cells (data not shown). This indicates that any variation in the formation of tumorspheres is due to reduced selfrenewal, rather than an inhibition of cell growth or cytotoxicity. Interestingly, shRNA-based knockdown of IKKa ( Figure 2c ) induced a statistically significant, approximately fivefold reduction in the self-renewal of SUM149 cells ( Figure 2d ) without altering overall cell growth ( Supplementary Figure 1b) . Treatment with an IKKb inhibitor (compound A 30 ) blocked both basal and tumor-necrosis factor-a-induced phosphorylation of p65, (Figure 2e ) and led to a reduction in tumorsphere formation that was very similar to the results obtained with shRNA knockdown of different IKK and NF-kB subunits (Figure 2f ). These data demonstrate that canonical NF-kB signaling, driven by IKK, promotes self-renewal in basal-like breast cancer cells (also see below).
In addition to the breast cancer cells analyzed above, we analyzed the role of NF-kB in the claudin-low representative cell line SUM159 (reviewed in Prat and Perou 31 and Prat et al. 32 ). Notably, similar results were obtained in SUM159 cells compared with SUM149 cells. Specifically, inhibition of IKK with compound A blocked NF-kB activity as measured by inhibition of phosphorylation of p65 and IkBa ( Supplementary Figure 2a ). In addition, and consistent with the findings using basal-like breast cancer cells, compound A blocked the formation of tumorspheres derived from SUM159 cells ( Supplementary Figure 2b) .
Non-canonical NF-kB activity is required for breast cancer cells to self-renew in vitro As shown above, IKKa contributes to the self-renewal of basal-like breast cancer cells. IKKa typically acts in non-canonical NF-kB signaling (reviewed in Ghosh and Karin 15 and Hayden and Ghosh 16 ), although it has recently been reported to promote canonical NF-kB signaling in breast cancer cells of the HER2 þ subtype. 33 formation was observed in cells in which p100/p52 was inhibited by siRNA ( Figure 3b ). To further address a role for non-canonical NF-kB in promoting breast cancer cell tumorsphere formation, RelB was knocked down with siRNA ( Figure 3a ). As shown in Figure 3b , knockdown of this component of the non-canonical NF-kB pathway suppressed tumorsphere formation in both SUM149 and MDA-MB231 cells. These data, along with those shown in Figure 2 , demonstrate that both canonical and non-canonical NF-kB are two signaling pathways that promote the self-renewal of breast cancer cells.
NF-kB promotes the self-renewal of breast cancer cells in vivo
In vivo, self-renewal is assayed by measuring the ability of cells to establish primary tumors when injected at limiting dilutions, which is specifically associated with the function of TICs. 2, 34, 35 To directly test the role of NF-kB in the self-renewal of basal-like breast cancer cells in vivo, SUM149 cells expressing empty vector or IkBa-SR at low (10 2 cells/100 ml) or high (10 6 cells/100 ml) density were prepared. These cells were injected into the mammary fat pad of nude mice and monitored as described in the methods. In these experiments, cells in which NF-kB signaling was deficient exhibited both delayed tumor onset and reduced overall tumor size (Table 1) . Specifically, while the high density of SUM149 cells expressing empty vector formed palpable tumors at 6 weeks and reached an average tumor volume of 138 mm 3 by 10 weeks, the high density of SUM149 cells expressing IkBa-SR did not form palpable tumors until week 8 and these tumors maintained a significantly smaller size (11 mm 3 ) at week 10 ( Table 1) . Importantly, the low density of SUM149 cells expressing empty vector formed palpable tumors at week 9 and these tumors continued to increase in size at a significant rate (Table 1) . Conversely, the low density of SUM149 cells expressing IkBa-SR did not form tumors (Table 1 ). These data demonstrate that NF-kB is required for xenograft-generated tumorigenesis in a context (limiting dilutions of cells, reviewed in Charafee-Jauffret et al. 2 ) that depends significantly on self-renewal.
Canonical and non-canonical NF-kB are activated in breast cancer TICs and required for maintenance of TICs in the bulk population The cell surface profile most commonly associated with breast cancer TICs is CD44 þ CD24 À , 7,13,34,36-38 although CD44 þ , EpCAM þ or ALDEFLUOR-positivity (which depends on the activity of the enzyme ALDH1) are also indicative of this subpopulation of cells. 12, 26, 34, [39] [40] [41] [42] [43] After examining the various cell surface profiles previously reported to enrich for TICs (data not shown), we chose to analyze CD44 þ cells, which could be identified, isolated and, more importantly, self-renewed efficiently (see below). By calculating the percentage yield from the isolation protocol, bulk populations of both the SUM149 (Figures 4g and h) and MDA-MB231 cell lines (data not shown) were found to contain B10% CD44 þ cells. This percentage is lower than earlier reports, 2,12,42 although different groups have reported a range of the proportion of TICs even within the same cell line, particularly when different cell surface markers are utilized. 12, 42 Although the bulk population and CD44 À cells each contain only a small proportion of cells that are positive for CD44, nearly all the cells in the CD44-isolated population robustly express CD44 (Figure 4a ). This confirms that the isolation protocol successfully enriches for CD44 þ cells. Notably, CD44 þ cells form tumorspheres significantly more efficiently than CD44 À cells (Figure 4b ), which demonstrates that the CD44 þ isolation protocol enriches for TIC function. Given that NF-kB is required for the self-renewal of TICs (Figures 2 and 3) , the activation of NF-kB was assessed in lysates from breast cancer TICs (CD44 þ cells) compared with lysates isolated from the bulk population of cells and non-TICs (CD44 À cells). Importantly, phosphorylation of p65 ( Figure 4c ) and levels of p52 ( Figure 4d ) are detected in CD44 þ cells in both SUM149 and MDA-MB231 cells, indicating that both canonical and non-canonical NF-kB signaling is activated in breast cancer TICs. As before, the role of NF-kB in TICs of the claudin-low SUM159 cells was also assessed. Specifically, CD44 þ cells isolated from SUM159 cells also exhibit elevated NF-kB activity, as measured by phosphorylation of p65 ( Supplementary Figure 2c) .
To determine if pathways upstream of NF-kB are also activated in breast cancer TICs, phosphorylation of IKKa and IKKb was assessed by immunoblot of cellular lysates prepared from the bulk population of SUM149 cells and its TIC and non-TIC counterparts. In support of the concept that NF-kB activation is IKK-dependent in these cells, an increased signal for phosphorylated IKKa/b was observed in TICs isolated from SUM149 cells (Figure 4e ). This fact is also consistent with evidence that canonical and non-canonical NF-kB pathways are important in TICs (Figures 2, 3, 4c and d) . Finally, the activation of TAK1, a kinase that is an upstream activator of IKK, 44 was examined. Similar to IKK, phosphorylation of TAK1, which is indicative of its activation, 45 was enriched in CD44 þ cells (Figure 4f) .
Given that NF-kB is preferentially activated in breast cancer TICs (Figures 4a-f ) and required for their self-renewal in vitro and in vivo (Figures 2 and 3 and Table 1) , it was determined whether NF-kB is important in the maintenance of TICs in the bulk population of basal-like breast cancer cells. To this end, the percentage of TICs in the bulk population of SUM149 cells was determined in the presence or absence of overexpression of IkBa-SR. The resulting data showed that inhibition of NF-kB reduced the percentage of CD44 þ cells by B50% (Figure 4g) . Similarly, stable knockdown of p65, IKKb or IKKa each reduced the percentage of CD44 þ cells by B50% (Figure 4h ). Taken together, these data demonstrate that both canonical and non-canonical NF-kB signaling is preferentially activated in breast cancer TICs, consistent with observations from TICs in the bulk population of cells (Figures 2 and 3) , and that NF-kB is important for the maintenance of the TIC population.
NF-kB promotes expression of markers of EMT in TICs and
transforming growth factor-b-induced self-renewal EMT is a process by which an epithelial cell releases from the basement membrane and transforms into a spindle-like, mesenchymal cell expressing vimentin and fibronectin (reviewed in Kalluri and Weinberg 46 ). EMT has been demonstrated to promote the self-renewal of immortalized breast cells, 36, 37 but this has not been examined in specific subtypes of breast cancer cells. NF-kB is one of the multiple signaling pathways implicated in the regulation of EMT, as activation of NF-kB is required for EMT that occurs during Ras-driven transformation. 47 Thus, we hypothesized that NF-kB promotes the function of breast cancer TICs by stimulating EMT. Expression of mesenchymal markers was analyzed in the bulk population of SUM149 or MDA-MB231 cells, and in CD44 þ and CD44 À cells. Both vimentin and fibronectin were detected in the bulk population as well as CD44 þ and CD44 À cells (data not shown). Importantly, expression of mesenchymal markers depends on NF-kB, as vimentin expression is decreased in the bulk population of SUM149 and MDA-MB231 cells expressing IkBa-SR (Figure 5a ). To extend these results, knockdown of the RelA/p65 NF-kB subunit reduced vimentin and fibronectin expression in SUM149 cells ( Supplementary Figure 3) . Transforming growth factor-b (TGFb) is a well-characterized inducer of EMT and has been shown to promote the self-renewal of at least immortalized breast cancer cells. 36 To first confirm that TGFb promotes self-renewal of basal-like breast cancer cells, 100 SUM149 cells expressing empty vector were plated on lowadhesion plates in serum-free media and treated every other day for 7 days with 10 ng/ml TGFb or vehicle control. Such treatment induced a statistically significant, threefold increase in the number of tumorspheres formed by these cells (Figure 5b ), suggesting that EMT is important for the function of TICs in basal-like breast cancer cells. Importantly, it was investigated whether the ability of TGFbinduced EMT to stimulate self-renewal of basal-like breast cancer cells depends on NF-kB. Specifically, SUM149 cells expressing IkBa-SR to inhibit NF-kB were also included in the above TGFb experiment. As previously observed (Figure 2b) , expression of IkBa-SR reduced the self-renewal of SUM149 cells (Figure 5b ). TGFb treatment of SUM149 cells expressing IkBa-SR resulted in the formation of a significantly smaller number of tumorspheres than TGFb treatment of cells with proficient NF-kB signaling (Figure 5b) . These data suggest that NF-kB promotes the selfrenewal of basal-like breast cancer cells at least in part by stimulating EMT.
IL-1b and IL-6 stimulate the self-renewal of basal-like breast cancer cells downstream of NF-kB Inflammatory cytokines that are NF-kB target genes have been demonstrated to be involved in self-renewal, 29, 48, 49 but the role of NF-kB in this process has not been thoroughly examined. We hypothesized that a subset of cytokine NF-kB target genes may be important to promote breast cancer TICs. To test this hypothesis, SUM149 cells were examined for expression of three inflammatory cytokines (IL-1b, IL-6 and IL-8), and for whether NF-kB is involved in regulating their expression in these cells. Analysis of mRNA expression by real-time PCR demonstrated that the IkBa-SRexpressing cells exhibit reduced levels of IL-1b, IL-6 and IL-8 mRNAs compared with vector control cells (Figure 6a ). In addition, enzyme-linked immunosorbent assay (ELISA) analysis revealed significantly decreased levels of secreted IL-1b, IL-6 and IL-8 in the media of SUM149 cells, in which NF-kB is inhibited compared with the vector control cells (Figure 6b ). These data confirm that NF-kB is critical for the expression and secretion of IL-1b, IL-6 and IL-8 in basal-like breast cancer cells.
To determine whether IL-1b, IL-6 or IL-8 promote the selfrenewal of basal-like breast cancer cells, 100 SUM149 cells expressing an empty vector were plated on low-adhesion plates in serum-free media and treated every other day for seven days with either IL-1b, IL-6, IL-8 or vehicle control. Tumorspheres were enumerated following the completion of this treatment schedule. Importantly, treatment of SUM149 cells expressing empty vector with either IL-1b or IL-6 potently increased the number of tumorspheres by fourfold and twofold, respectively (Figure 6c) . These data suggest that IL-1b and IL-6 are important modulators of the ability of basal-like breast cancer cells to self-renew. Treatment of SUM149 cells with CXCL7, the product of an NF-kB target gene, produced small increases in the ability of these cells to form tumorspheres (data not shown). Conversely, treatment with exogenous IL-8 failed to promote the formation of tumorspheres in control SUM149 cells (Figure 6c ). Consistent with the results described above, addition of an IL-6 receptor antagonistic antibody suppressed tumorsphere formation B25% and addition of recombinant IL-1b receptor antagonist suppressed tumorsphere formation B30% ( Supplementary Figure 4) .
As IL-1b and IL-6 are known NF-kB target genes 16 and were upregulated by NF-kB in SUM149 cells (Figures 6a and b) , we investigated whether NF-kB promotes self-renewal by inducing their expression and secretion. Specifically, we tested whether treatment with IL-1b or IL-6 can rescue the ability to self-renew in SUM149 cells in which NF-kB is inhibited. To do so, the above experiment was also performed using SUM149 cells expressing IkBa-SR. As before (Figure 2b) , expression of IkBa-SR reduces the ability of untreated SUM149 to form tumorspheres (Figure 6c) . Notably, treatment with either IL-1b or IL-6, but not IL-8, partially rescued the ability of IkBa-SR-expressing cells to form tumorspheres (Figure 6c ). These data indicate that IL-1b and IL-6 promote self-renewal of basal-like breast cancer cells downstream of NF-kB.
DISCUSSION
Most solid tumors, including those of the breast, 50 are characterized by a hierarchy of cells including a sub-population of cells that can self-renew and give rise to the differentiated cells that comprise the bulk of the tumor. These TICs promote tumor initiation, cellular motility and invasiveness, tumor recurrence, and are typically radio-and chemoresistant. As such, characterizing the functional and phenotypic differences between the bulk population of cancer cells and TICs is critical in understanding tumorigenesis and gaining insight into new approaches for cancer therapy. The transcription factor NF-kB is widely implicated in a variety of oncogenic mechanisms in both hematological malignancies as well as solid tumors, including cancer cell proliferation, survival and metastasis. 18, 19 Here, we have shown the involvement of NF-kB in promoting TICs in a basal-like breast cancer cell line, SUM149, and two claudin-low lines, MDA-MB231 and SUM159. Interestingly, both canonical and non-canonical NF-kB appear to be important in promoting TICs in these cancer cell lines. It will be interesting to determine if distinct or overlapping functions of these two pathways are operative in the maintenance of TICs. Work by others has indicated the association of NF-kB activity with other TICs. For example, prostate cancer TICs exhibit increased canonical NF-kB activity. 51 Also, published work indicates that canonical NF-kB signaling is important in TICs in the HER2 þ breast tumor subtype. 25, 26, 52 One study utilized inhibitors that are not specific to NF-kB to suggest an involvement of NF-kB in promoting MCF7 breast cancer tumorspheres. 53 We propose that NF-kB promotes the function of TICs through several mechanisms. First, NF-kB may promote TIC self-renewal by stimulating EMT. Second, NF-kB promotes TICs by stimulating the expression of cytokines, such as IL-1b and IL-6. Notably, IL-6 has been implicated in the induction of EMT in breast cancer cells. 54 Several reports support the finding that IL-6 promotes the function of TICs downstream of NF-kB. MCF10A cells transformed by Src gain the ability to form tumorspheres in a manner that depends on expression of IL-6. 29 In addition, it was found that treatment of a claudin-low breast cancer cell line with IL-6 increased the proportion of TICs. 49 That NF-kB upregulates the expression of many cytokines, and correspondingly can be activated downstream of these cytokines, indicates an important mechanism for sustaining NF-kB activation and promoting its TIC self-renewal properties in certain cancers. Additional roles for NF-kB in TICs likely include the upregulation of other key genes. Given the potential benefit of targeting TICs in breast cancer patients, the identification of NF-kB as a key regulator of TICs in basal-like and claudin-low breast cancer cells, along with previous work studying NF-kB in Her2 þ TICs, represents a significant opportunity for the development of more effective chemotherapeutics for breast cancer.
MATERIALS AND METHODS
Cell culture and reagents SUM149, MDA-MB231, SUM159 and MCF10A cells were maintained as described (Supplementary Materials). Details regarding shRNA constructs and antibodies are also found in Supplementary Materials.
Tumorsphere formation assay
Cells growing adherently in serum-containing media were trypsinized with TrypLE Select (Invitrogen, Grand Island, NY, USA) to generate a single cell solution and then enumerated using a hemocytometer. Subsequently, 100 cells per well were plated in 3 ml of Mammocult media (Stem Cell Technologies, Vancouver, BC, Canada) on six-well low-adhesion plates (Corning, Corning, NY, USA). Cells were treated with compound A, TGFb, cytokines or vehicle controls as described in the text. The number of tumorspheres formed per well were counted visually. Cell density is a critical parameter in the tumorsphere formation assay and cells may aggregate if cell density is too high. 28 As such, we ensured that a disperse, low-density (100 cells in 3 ml of media) solution of cells was prepared for each tumorsphere formation assay to avoid cell aggregation. Furthermore, plates were not moved during the growth period to avoid cell aggregation. These precautions were taken to ensure the clonality of tumorspheres formed during this assay. 28 Immunoblotting See Supplementary Materials. 
Fluorescence-activated cell sorting

Isolation of TICs
Cells were trypsinized using TrypLE Select (Invitrogen) and dissociated by incubation in Accutase (Invitrogen) for 15 min at 37 1C. The resulting cell solution was passed through a pre-separation filter (Miltenyi Biotec, Auburn, CA, USA) to generate a single cell suspension. Cells were then incubated with 100 ml of Dead Cell Removal microbeads (Miltenyi Biotec) per 10 7 cells for 15 min at room temperature. Subsequently, the cell and microbead solution was resuspended in 20 ml of MACS buffer (Miltenyi Biotec) and passed through an LS column (Miltenyi Biotec) that was premoistened with MACS buffer and placed in a magnetized field. Live cells from the eluate were collected. Next, the resulting live cells were resuspended in 100 ml of MACS buffer per 10 7 cells and incubated with 75 ml of CD44 microbeads (Miltenyi Biotec) and 75 ml of FcR blocking reagent (Miltenyi Biotec) per 10 7 cells for 30 min at 4 1C. Subsequently, the cell and microbead solution was resuspended in 20 ml of MACS buffer (Miltenyi Biotec) passed through a LS column (Miltenyi Biotec) that was pre-moistened with MACS buffer and placed in a magnetic field. The CD44 À cells in the eluate were collected, the LS column was removed from the magnetized field and the CD44 þ cells were collected from the column in 5 ml of MACS buffer.
MTT
The MTT assays were performed as previously described 55 Enzyme-linked immunosorbent assay ELISA kits (BD Biosciences, San Jose, CA, USA) were utilized according to the manufacturer's instructions.
Quantitative real-time PCR
Real-time PCR was performed and analyzed as previously described 56 using Taqman Gene Expression Assay primer-probe sets from Applied Biosystems (Grand Island, NY, USA).
Xenograft tumor formation
Cells were trypsinized with TrypLE Select (Invitrogen), a single cell solution was generated and the cells were enumerated using a hemocytometer. Cell solutions were generated in 50:50 media:Matrigel (BD Biosciences) at concentrations of 10 6 or 10 2 cells/100 ml. Further, 100 ml of the resulting solutions were orthotopically injected into the mammary fat pad of athymic nude-Foxn1 nu mice (Harlan Laboratories, Indianapolis, IN, USA). Injection of each cell solution was repeated in triplicate. All murine studies were conducted in accordance with guidelines from the UNC Institutional Animal Care and Use Committee on approved protocol 08-266.
ABBREVIATIONS
EMT, epithelial-to-mesenchymal transition; IkB, inhibitor of kB; IKK, IkB kinase; IL, interleukin; NF-kB, nuclear factor-kB; TIC, tumor-initiating cell; TGFb, transforming growth factor-b
